SnapshotGLO Wound Imaging Device, Model KB100, KB100AA. Recall
SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.
FDA recall Class II
Ongoing
FDA lists this Class II recall for SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2775-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jun 30, 2026
- FDA report date
- Jul 29, 2026
- Quantity in commerce
- 77
- Distribution
- See key details
- FDA cause
- Software design
What is being recalled?
SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.
Affected model & UDI checker
Search the exact identifiers published for Z-2775-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| KB100 | SnapshotGLO Wound Imaging Device, Model KB100, KB100AA. | Check source notice | Not specified |
FDA code information
UDI-DI: B376KB1000, Software Revisions v4.2.0 and v4.1.3
Why was this product recalled?
The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected device will not resume charging when reconnected to power and becomes temporarily unusable/ unavailable for wound imaging until corrected.
What actions did KENT IMAGING, INC. take?
On 6/30/2026, correction and removal notices were emailed to customers who were asked to do the following: 1) Discontinue use of the affected unit(s) and remove them from clinical service. 2) Contact Kent Imaging at customerservice@kentimaging.com to confirm return shipping instructions. 3) Pending return, keep the device charged and avoid allowing the battery to fully deplete, to prevent the unit from becoming temporarily inoperable in the interim. 4) Within 5 business days of receipt of this notice, please confirm receipt and current status of the listed unit(s) by replying to this letter or contacting Hitalo Arume directly. Distributor was asked to: a) Identify the current location/holder of each of these 6 units; b) Coordinate scheduling of a brief remote session between Kent Imaging's technical support team and each unit's user; and c) Confirm completion of each update on the attached Device Reconciliation Form. d) For units that require physical return, quarantine and stop distribution. For units distributed, identify each affected customer, coordinate on-site access for collection, and arrange return shipment to Kent Imaging. Questions can be directed to hitaloa@kentimaging.com
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2775-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology